Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed and/or sunitinib as second-line therapy in patients with stage IIIB or stage IV non-small cell lung canc…
-
CLINICAL_TRIALS withdrawal · 2015-03-19Clinical Trial Update: Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC [Phase 1]
A Phase I study evaluating active breathing control with simultaneous boost for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 trial update reports on preoperative or postoperative therapy for stages IB to IIIA non-small cell lung cancer and notes the st…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
A completed clinical trial evaluated the effect of paclitaxel/cisplatin chemotherapy on development of dysgeusia in patients with non-small …
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial results evaluate cetuximab with radiation therapy for stage III non-small cell lung cancer. The study is completed with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-13Clinical Trial Update: Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI [Phase 1]
Phase 1 clinical trial update evaluating the combination of icotinib and arsenic trioxide for non-small cell lung cancer with resistance to …
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Gefitinib Combined With Thalidomide to Treat NSCLC [Phase 2, Phase 3]
Update on a phase 2/phase 3 clinical trial evaluating gefitinib in combination with thalidomide for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2015-03-11Clinical Trial Update: Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating temozolomide with concomitant whole-brain radiotherapy in patients with non-small cell lung cancer and b…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial of E7080 (lenvatinib) in combination with carboplatin and paclitaxel in non-small cell lung cancer has completed with results …
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma [Phase 2]
Phase 2 clinical trial of ILX651 for locally advanced or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
The MD Anderson Cancer Center–sponsored Phase 1/Phase 2 trial in non-small cell lung cancer has been withdrawn.
-
EMA approval · 2015-02-27Zykadia recommended for approval in advanced non small cell lung cancer
The European Medicines Agency recommended approving Zykadia for use in adults with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2015-02-26Clinical Trial Update: Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash [NA]
A clinical trial assessing Erlotinib pharmacokinetics during doxycycline treatment for Erlotinib-induced rash has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations [Phase 3]
Phase 3 trial comparing erlotinib (Tarceva) to gemcitabine/cisplatin as first-line treatment in EGFR-mutant non-small cell lung cancer compl…
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy [NA]
The trial studied residual hypermethylation in early-stage non-small cell lung cancer as part of adjuvant therapy and a preventive strategy.…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating Tarceva (erlotinib) with standard-of-care chemotherapy in advanced, recurrent, or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) [Phase 3]
A Phase 3 trial (CURRENTS) comparing two Tarceva (erlotinib) dose regimens in current smokers with advanced or metastatic non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]
A Phase 1 study of MDX-1106 in patients with selected refractory or relapsed malignancies has completed, with results posted in 2015. The tr…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer [NA]
The clinical trial update notes that the Shrinking Target Adaptive Radiotherapy study for locally advanced non-small cell lung cancer has be…
-
CLINICAL_TRIALS withdrawal · 2015-02-16Clinical Trial Update: NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy [Phase 3]
A Phase 3 trial investigating relapse therapy for non-small cell lung cancer after surgery and perioperative chemotherapy has been terminate…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC [Phase 3]
This entry reports a Phase 3 clinical trial investigating erlotinib at 100 mg or 150 mg in patients with EGFR-mutated non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer [Phase 3]
Phase 3 randomized trial evaluating concomitant radiochemotherapy in non-small cell lung cancer; the study status was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy [Phase 2]
A Phase 2 trial evaluating lobectomy after induction chemotherapy and mediastinal radiochemotherapy in unresectable stage III non-small cell…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Powered Echelon Device in VATS Surgery
The clinical trial evaluating Ethicon Endo-Surgery's Powered Echelon device used in video-assisted thoracoscopic surgery for non-small cell …
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic Country [NA]
This entry reports the completion of a clinical trial evaluating Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in no…